EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Risk Factors for Colonization With Extended-Spectrum Cephalosporin-Resistant and Carbapenem-Resistant Enterobacterales Among Hospitalized Patients in Kenya: An Antibiotic Resistance in Communities and Hospitals (ARCH) Study

Sylvia Omulo, Teresa Ita, Robert Mugoh, Charchil Ayodo, Ulzii Luvsansharav, Susan Bollinger, Ashley Styczynski, Brooke M Ramay, Mark A Caudell, Guy H Palmer, Samuel Kariuki, Douglas R Call iD und 1 weitere

Clinical Infectious Diseases · 05.07.2023 · 77 (Supplement_1) · S97-S103

DOI: 10.1093/cid/ciad258 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 05.07.2023. Verfasst von Sylvia Omulo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Paul G. Allen School for Global Health, Washington State University, Pullman, Washington, USA. Hauptthemen laut MEDLINE: Cephalosporins, Carbapenems. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CGH CDC HHS, US Centers for Disease Control and Prevention.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The spread of extended-spectrum cephalosporin-resistant Enterobacterales (ESCrE) and carbapenem-resistant Enterobacterales (CRE) represents a significant global public health threat. We identified putative risk factors for ESCrE and CRE colonization among patients in 1 urban and 3 rural hospitals in Kenya.

Methods

During a January 2019 and March 2020 cross-sectional study, stool samples were collected from randomized inpatients and tested for ESCrE and CRE. The Vitek2 instrument was used for isolate confirmation and antibiotic susceptibility testing, and least absolute shrinkage and selection operator (LASSO) regression models were used to identify colonization risk factors while varying antibiotic use measures.

Results

Most (76%) of the 840 enrolled participants received ≥1 antibiotic in the 14 days preceding their enrollment, primarily ceftriaxone (46%), metronidazole (28%), or benzylpenicillin-gentamycin (23%). For LASSO models that included ceftriaxone administration, ESCrE colonization odds were higher among patients hospitalized for ≥3 days (odds ratio, 2.32 [95% confidence interval, 1.6–3.37]; P < .001), intubated patients (1.73 [1.03–2.91]; P = .009), and persons living with human immunodeficiency virus (1.70 [1.03–2.8]; P = .029). CRE colonization odds were higher among patients receiving ceftriaxone (odds ratio, 2.23 [95% confidence interval, 1.14–4.38]; P = .025) and for every additional day of antibiotic use (1.08 [1.03–1.13]; P = .002).

Conclusions

While CRE colonization was strongly associated with ceftriaxone use and duration of antibiotic use, the odds of ESCrE colonization increased with exposure to the hospital setting and invasive medical devices, which may reflect nosocomial transmission. These data suggest several areas where hospitals can intervene to prevent colonization among hospitalized patients, both through robust infection prevention and control practices and antibiotic stewardship programs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CephalosporinsCarbapenemsHumansCeftriaxoneKenyaCross-Sectional StudiesAnti-Bacterial AgentsHospitalsMonobactamsDrug Resistance, MicrobialRisk Factors

Stichwörter der Autor:innen

Kenyaantimicrobial resistancecolonizationhospitals

Substanzen

CephalosporinsCarbapenemsCeftriaxoneAnti-Bacterial AgentsMonobactams

Autor:innen und Institutionen

  • Paul G. Allen School for Global Health, Washington State University, Pullman, Washington, USA.
  • Washington State University Global Health-Kenya, Nairobi, Kenya.
  • University of Nairobi Institute of Tropical and Infectious Diseases, Nairobi, Kenya.
  • Division of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Center for Health Studies, Universidad del Valle de Guatemala, Guatemala City, Guatemala.
  • Kenya Medical Research Institute, Nairobi, Kenya.

ORCID-Profile: Douglas R Call

Förderung

  • CGH CDC HHS
  • US Centers for Disease Control and Prevention

Zitieren

APA

Omulo, S., Ita, T., Mugoh, R., Ayodo, C., Luvsansharav, U., Bollinger, S., Styczynski, A., Ramay, B. M., Caudell, M. A., Palmer, G. H., Kariuki, S., Call, D. R., & Smith, R. M. (2023). Risk Factors for Colonization With Extended-Spectrum Cephalosporin-Resistant and Carbapenem-Resistant Enterobacterales Among Hospitalized Patients in Kenya: An Antibiotic Resistance in Communities and Hospitals (ARCH) Study. Clinical Infectious Diseases, 77(Supplement_1), S97-S103. https://doi.org/10.1093/cid/ciad258

Vancouver

Omulo S, Ita T, Mugoh R, Ayodo C, Luvsansharav U, Bollinger S, et al. Risk Factors for Colonization With Extended-Spectrum Cephalosporin-Resistant and Carbapenem-Resistant Enterobacterales Among Hospitalized Patients in Kenya: An Antibiotic Resistance in Communities and Hospitals (ARCH) Study. Clinical Infectious Diseases. 2023;77(Supplement_1):S97-S103. doi:10.1093/cid/ciad258

BibTeX
@article{Omulo2023,
  author = {Omulo, Sylvia and Ita, Teresa and Mugoh, Robert and Ayodo, Charchil and Luvsansharav, Ulzii and Bollinger, Susan and Styczynski, Ashley and Ramay, Brooke M and Caudell, Mark A and Palmer, Guy H and Kariuki, Samuel and Call, Douglas R and Smith, Rachel M},
  title = {Risk Factors for Colonization With Extended-Spectrum Cephalosporin-Resistant and Carbapenem-Resistant Enterobacterales Among Hospitalized Patients in Kenya: An Antibiotic Resistance in Communities and Hospitals (ARCH) Study},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  volume = {77},
  number = {Supplement_1},
  pages = {S97--S103},
  doi = {10.1093/cid/ciad258}
}
Kostenlos starten →